Revision to Unit 3

Edit Answers
12345678910111213141516171819
Across
  1. 4. - Inactive substance used as a control in clinical trials
  2. 7. - Application submitted to FDA for drug marketing approval (Abbreviation)
  3. 9. - Study of how a drug moves through the body
  4. 11. - European agency responsible for drug evaluation (Abbreviation)
  5. 13. - Application submitted to FDA to begin clinical trials (Abbreviation)
  6. 14. - The ability of a drug to produce the desired therapeutic effect
  7. 18. Drug - A medication developed for rare diseases
  8. 19. - International Conference on Harmonisation (Abbreviation)
Down
  1. 1. - Products derived from living organisms used in medicine
  2. 2. - Study of the effects of drugs on the body
  3. 3. - The study of the adverse effects of chemicals on living organisms
  4. 5. - Information provided with a drug product, including usage and safety
  5. 6. Event - Unintended medical occurrence in a patient during treatment
  6. 8. - Chemistry, Manufacturing, and Controls section in drug applications (Abbreviation)
  7. 10. vitro - Studies conducted outside of living organisms, usually in a lab (Latin term)
  8. 12. - Applications for biological products (Abbreviation)
  9. 15. - U.S. agency responsible for drug approval (Abbreviation)
  10. 16. vivo - Studies conducted in living organisms (Latin term)
  11. 17. - Standard Operating Procedure (Abbreviation)